134
Views
0
CrossRef citations to date
0
Altmetric
Original

Understanding myocardial ischemic preconditioning, and the implications for a role of adenosine catabolism

Pages 37-59 | Received 07 Oct 2002, Accepted 21 Oct 2002, Published online: 12 Jul 2009

References

  • Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB (1986) Four brief periods of myocar-dial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 251: H1306–H1315.
  • Swain JL, Sabina RL, Hines JJ, Greenfield JC Jr, Holmes EW (1984) Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds. Cardiovasc Res 18: 264–269.
  • Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124–1136.
  • Wayne EJ, Graybiel A (1934) Observation on the sffect of food, gastric dilatation, external tem-perature and repeated exercise on angina of effort, with note on angina sine dolore. Clin Sci 1: 287–304.
  • Edwards RJ, Saurin AT, Rakhit RD, Marber MS (2000) Therapeutic potential of ischemic precon-ditioning. J Clin Pharmacol 50: 87–97.
  • Marber MS, Joy MD, Yellon DM (1994) Is warm-up in angina ischaemic preconditioning? Br Heart J 72: 213–215.
  • Maybaum S, Ilan M, Mogilevsky J, Tzivoni D (1996) Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning. Am J Cardiol 78: 1087–1091.
  • Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK (1990) Adap-tation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 82: 2044–2051.
  • Okishige K, Yamashita K, Yoshinaga H, Azegami K, Satoh T, Goseki Y, Fujii S, Ohira H, Satake S (1996) Electrophysiologic effects of ischemic preconditioning on QT dispersion during coro-nary angioplasty. J Am Coll Cardiol 28: 70–73.
  • Sakata Y, Kodama K, Kitakaze M, Masuyama T, Hirayama A, Lim YJ, Ishikura F, Sakai A, Adachi T, Hori M (1997) Different mechanisms of ischemic adaptation to repeated coronary occlusion in patients with and without recruitable collateral circulation. J Am Coll Cardiol 30: 1679–1686.
  • Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, Seiler C (1999) Is the development of myocardial tolerance to repeated ischemia in humans due to reconditioning or to collateral recruitment? J Am Coll Cardiol 33: 1027–1035.
  • Dupouy P, Geschwind H, Pelle G, Aptecar E, Hittinger L, El Ghalid A, Dubois-Rande JL (1996) Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol 27: 1374–1380.
  • Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, Chiariello L, Gioffre PA (1994) Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 90: 700–705.
  • Claeys MJ, Vrints CJ, Bosmans JM, Conraads VM, Snoeck JP (1996) Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischaemic preconditioning. Eur Heart J 17: 539–544.
  • Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P. Pantoli D, Rusticali F (1995) Prodromal angina limits infarct size. A role for ischemic preconditioning. Circulation 91: 291–297.
  • Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald E (1998) Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97: 1042–1045.
  • Iwasaka T, Nakamura S, Karakawa M, Sugiura T, Inada M (1994) Cardioprotective effect of unstable angina prior to acute anterior myocardial infarction. Chest 105: 57–61.
  • Kloner RA, Shook T, Przyldenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson M, Poole WK, Cannon CP, et al. (1995) Previous angina alters in-hospital outcome in TIMI 4. A clin-ical correlate to preconditioning? Circulation 91: 37–45.
  • Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. Lancet 342: 276–277.
  • Speechly-Dick ME, Grover GJ, Yellon DM (1995) Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K1 channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030–1035.
  • Ikonomidis JS, Tumiati LC, Weisel RD, Mickle DA, Li RK (1994) Preconditioning human ven-tricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 28: 1285–1291.
  • Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey IM (1991) Protection against infarction afforded by preconditioning is mediated by Al adenosine receptors in rabbit heart. Circulation 84: 350–356.
  • Liu GS, Richards SC, Olsson RA, Mullane K, Walsh RS, Downey IM (1994) Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rab-bit heart. Cardiovasc Res 28: 1057–1061.
  • Schultz JE, Rose E, Yao Z, Gross GJ (1995) Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 268: H2157–2161.
  • Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey .IM (1995) Role of bradykinin in pro-tection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611–621.
  • Liu Y, Tsuchida A, Cohen MV, Downey IM (1995) Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883–892.
  • Banerjee A, Locke-Winter C, Rogers KB, Mitchell MB, Brew EC, Cairns CB, Bensard DD, Harken AH (1993) Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res 73: 656–670.
  • Wang P, Gallagher KP, Downey IM, Cohen MV (1996) Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart. J Mol Cell Cardiol 28: 579–588.
  • Yao Z, Gross GJ (1993) Acetylcholine mimics ischemic preconditioning via a glibenclamide-sen-sitive mechanism in dogs. Am J Physiol 264: H2221–H2225.
  • Stefano GB, Neenan K, Cadet P, Magazine H, Bilfinger TV (2001) Ischemic preconditioning - an opiate constitutive nitric oxide molecular hypothesis. Med Sci Monit 7: 1357–1375.
  • Pagliaro P, Gattullo D, Rastaldo R, Losano G (2001) Ischemic preconditioning: from the first to the second window of protection. Life Sci 69: 1–15.
  • Baines CP, Goto M, Downey .IM (1997) Oxygen radicals released during ischemic precondition-ing contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29: 207–216.
  • Cohen MV, Baines CP, Downey .IM (2000) Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 62: 79–109.
  • Edwards RJ, Saurin AT, Rakhit RD, Marber MS (2000) Therapeutic potential of ischaemic pre-conditioning. Br J Clin Pharmacol 50: 87–97.
  • de Jong JW, de Jonge R, Keijzer E, Bradamante S (2000) The role of adenosine in precondition-ing. Pharmacol Ther 87: 141–149.
  • Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C (1994) Its role in ischemic pre-conditioning in the rat. Circ Res 75: 586–590.
  • Ytrehus K, Liu Y, Downey .IM (1994) Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145–H1152.
  • Yang XM, Sato H, Downey JM, Cohen MV (1997) Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 29: 991–999.
  • Liu Y, Ytrehus K, Downey JM (1994) Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661–668.
  • Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R (1997) Ischemic precondi-tioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404–414.
  • Goldberg M, Zhang HL, Steinberg SF (1997) Hypoxia alters the subcellular distribution of protein kinase C isoforms in neonatal rat ventricular myocytes. J Clin Invest 99: 55–61.
  • Maulik N, Watanabe M, Zu YL, Huang CK, Cordis GA, Schley JA, Das DK (1996) Ischemic pre-conditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233–237.
  • Baines CP, Wang L, Cohen MV, Downey IM (1998) Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 30: 383–392.
  • Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, Critz SD (2000) Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 86: 144–151.
  • Baines CP, Liu GS, Birincioglu M, Critz SD, Cohen MV, Downey JM (1999) Ischemic precondi-tioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. Am J Physiol 276: H1361–H1368.
  • Weinbrenner C, Liu GS, Cohen MV, Downey JM (1997) Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2383–2391.
  • Noma A (1983) ATP-regulated K+ channels in cardiac muscle. Nature 305: 147–148.
  • Gross GJ, Auchampach JA (1992) Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223–233.
  • Schulz R, Rose J, Heusch G (1994) Involvement of activation of ATP-dependent potassium chan-nels in ischemic preconditioning in swine. Am J Physiol 267: H1341–H1352.
  • Grover GJ (1997) Pharmacology of ATP-sensitive potassium channel (KATP) openers in models of myocardial ischemia and reperfusion. Can J Physiol Pharmacol 75: 309–315.
  • Yao Z, Gross GJ (1994) Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 89: 1769–1775.
  • Liang BT (1996) Direct preconditioning of cardiac ventricular myocytes via adenosine Al recep-tor and KATP channel. Am J Physiol 271: H1769–H1777.
  • Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA, Grover GJ (1997) Cardioprotective effect of diazoxide and its interaction with mito-chondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81: 1072–1082.
  • Liu Y, Sato T, O'Rourke B, Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463–2469.
  • Gross GJ, Fryer RM (1999) Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ Res 84: 973–979.
  • Gottlieb RA, Gruol DL, Zhu JY, Engler RL (1996) Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97: 2391–2398.
  • Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913–931.
  • Jennings RB, Reimer KA, Steenbergen C (1991) Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol 23: 1383–1395.
  • Vuorinen K, Ylitalo K, Peuhkurinen K, Raatikainen P. Ala-Rami A, Hassinen IE (1995) Mecha-nisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase. Circulation 91: 2810–2818.
  • Vander Heide RS, Hill ML, Reimer KA, Jennings RB (1996) Effect of reversible ischemia on the activity of the mitochondrial ATPase: relationship to ischemic preconditioning. J Mol Cell Cardiol 28: 103–112.
  • Green DW, Murray UN, Sleph PG, Wang FL, Baird AJ, Rogers WL, Grover GJ (1998) Precondi-tioning in rat hearts is independent of mitochondrial FIFO ATPase inhibition. Am J Physiol 274: H90–H97.
  • Shiki K, Hearse DJ (1987) Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol 253: H1470–H1476.
  • Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M (1993) Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293–1299.
  • Yang XM, Arnoult S, Tsuchida A, Cope D, Thornton JD, Daly JF, Cohen MV, Downey IM (1993) The protection of ischaemic preconditioning can be reinstated in the rabbit heart after the initial protection has waned. Cardiovasc Res 27: 556–558.
  • Yellon DM, Baxter GF (1995) A "second window of protection" or delayed preconditioning phe-nomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023–1034.
  • Qiu Y, Tang XL, Park SW, Sun JZ, Kalya A, BoIli R (1997) The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion. Circ Res 80: 730–742.
  • Tang XL, Qiu Y, Park SW, Sun JZ, Kalya A, BoIli R (1996) Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79: 424–434.
  • Baxter GF, Goma FM, Yellon DM (1997) Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159–167.
  • BoIli R (2000) The late phase of preconditioning. Circ Res 87: 972–983.
  • Baxter GF, Goma FM, Yellon DM (1995) Involvement of protein kinase C in the delayed cyto-protection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222–224.
  • Dawn B, Xuan YT, Qiu Y, Takano H, Tang XL, Ping P, Banerjee S, Hill M, BoIli R (1999) Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res 85: 1154–1163.
  • Ping P, Zhang J, Cao X, Li RC, Kong D, Tang XL, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, BoIli R (1999) PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol 276: H1468–H1481.
  • Rizvi A, Tang XL, Qiu Y, Xuan YT, Takano H, Jadoon AK, BoIli R (1999) Increased protein syn-thesis is necessary for the development of late preconditioning against myocardial stunning. Am J Physiol 277: H874–H884.
  • Plumier JC, Ross BM, Currie RW, Angelidis CE, Kazlaris H, Kollias G, Pagoulatos GN (1995) Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J Clin Invest 95: 1854–1860.
  • Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH (1995) Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J Clin Invest 95: 1446–1456.
  • Knowlton AA, Brecher P, Apstein CS (1991) Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest 87: 139–147.
  • Marber MS, Latchman DS, Walker JM, Yellon DM (1993) Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Cir-culation 88: 1264–1272.
  • Kukreja RC, Qian YZ, Okubo S, Flaherty EE (1999) Role of protein kinase C and 72 kDa heat shock protein in ischemic tolerance following heat stress in the rat heart. Mol Cell Biochem 195: 123–131.
  • Qian YZ, Bernardo NL, Nayeem MA, Chelliah J, Kukreja RC (1999) Induction of 72-kDa heat shock protein does not produce second window of ischemic preconditioning in rat heart. Am J Physiol 276: H224–H234.
  • BoIli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, Jadoon AK (1997) Evidence that late pre-conditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42–52.
  • BoIli R, Manchikalapudi S, Tang XL, Takano H, Qiu Y, Guo Y, Zhang Q, Jadoon AK (1997) The protective effect of late preconditioning against myocardial stunning in conscious rabbits is medi-ated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res 81: 1094–1107.
  • Takano H, Manchikalapudi S, Tang XL, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, BoIli R (1998) Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in con-scious rabbits. Circulation 98: 441–449.
  • Xuan YT, Tang XL, Qiu Y, Banerjee S, Takano H, Han H, Bolli R (2000) Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279: H2360–H2371.
  • Bernardo NL, Okubo S, Maaieh MM, Wood MA, Kukreja RC (1999) Delayed preconditioning with adenosine is mediated by opening of ATP-sensitive K+ channels in rabbit heart.Am J Physi-ol 277: H128–H135.
  • Bernardo NL, D'Angelo M, Okubo S, Joy A, Kukreja RC (1999) Delayed ischemic precondition-ing is mediated by opening of ATP-sensitive potassium channels in the rabbit heart. Am J Physi-ol 276: H1323–H1330.
  • Takano H, Bolli R, Black RG Jr, Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA (2001) A(1) or A(3) adenosine receptors induce late preconditioning against infarction in con-scious rabbits by different mechanisms. Circ Res 88: 520–528.
  • Baxter GF, Yellon DM (1999) ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine Al receptor activation. J Mol Cell Cardiol 31: 981–989.
  • Fryer RM, Hsu AK, Eells JT, Nagase H, Gross GJ (1999) Opioid-induced second window of car-dioprotection: potential role of mitochondrial KATP channels. Circ Res 84: 846–851.
  • Takano H, Tang XL, Bolli R (2000) Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol 279: H2350–H2359.
  • Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R (2000) Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic precondi-tioning in conscious rabbits. Proc Natl Acad Sci USA 97: 10197–10202.
  • Shinmura K, Liu S-Q, Tang XL, Kodani E, Xuan YT, Liu SQ, Bhatnagar A, Bolli R (2002) Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ Res 91: 240–246.
  • Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic 'precondi-tioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Cir-culation 87: 893–899.
  • Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD (1996) Myocardial pro-tection by brief ischemia in noncardiac tissue. Circulation 94: 2193–2200.
  • Birnbaum Y, Hale SL, Kloner RA (1997) Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation 96: 1641–1646.
  • Takaoka A, Nakae I, Mitsunami K, Yabe T, Morikawa S, Inubushi T, Kinoshita M (1999) Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of "remote preconditioning". J Am Coll Car-diol 33: 556–564.
  • Schoemaker RG, van Heijningen CL (2000) Bradykinin mediates cardiac preconditioning at a distance.Am J Physiol Heart Circ Physiol 278: H1571–H1576.
  • Zager RA, Baltes LA, Sharma HM, Jurkowitz MS (1984) Responses of the ischemic acute renal failure kidney to additional ischemic events. Kidney Int 26: 689–700.
  • Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, Yagi T, Nakagami M, Takada Y, Morimoto T, Yamaoka Y (1996) Ischemic preconditioning of the liver in rats: impli-cations of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J Lab Clin Med 128: 251–258.
  • Liu Y, Kato H, Nakata N, Kogure K (1992) Protection of rat hippocampus against ischemic neu-ronal damage by pretreatment with sublethal ischemia. Brain Res 586: 121–124.
  • Speechly-Dick ME, Baxter GF, Yellon DM (1994) Ischaemic preconditioning protects hypertro-phied myocardium.Cardiovasc Res 28: 1025–1029.
  • Boutros A, Wang J (1995) Ischemic preconditioning, adenosine and bethanechol protect sponta-neously hypertensive isolated rat hearts. J Pharmacol Exp Ther 275: 1148–1156.
  • Randall MD, Gardiner SM, Bennett T (1997) Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2) 27) hypertensive rat. Cardiovasc Res 33: 400–409.
  • Pantos CI, Davos CH, Carageorgiou HC, Varonos DV, Cokkinos DV (1996) Ischaemic precon-ditioning protects against myocardial dysfunction caused by ischaemia in isolated hypertrophied rat hearts. Basic Res Cardiol 91: 444–449.
  • Lu HR, Yu F, Dai DZ, Remeysen P. De Clerck F (1999) Reduction in QT dispersion and ventric-ular arrhythmias by ischaemic preconditioning in anaesthetized, normotensive and spontaneously hypertensive rats. Fundam Clin Pharmacol 13: 445–454.
  • Kapadia SJ, Terlato JS, Most AS (1997) Presence of a critical coronary artery stenosis does not abolish the protective effect of ischemic preconditioning. Circulation. 95: 1286–1292.
  • Szilvassy Z, Ferdinandy P. Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M (1995) The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholestero-laemia. J Mol Cell Cardiol 27: 2559–2569.
  • Ferdinandy P. Szilvassy Z, Horvath LI, Csont T, Csonka C, Nagy E, Szentgyorgyi R, Nagy I, Koltai M, Dux L (1997) Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 29: 3321–3333.
  • Herlitz J, Malmberg K, Karlson BW, Ryden L, Hjalmarson A (1988) Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction. Acta Med Scand 224: 31–38.
  • Malmberg K, Ryden L (1988) Myocardial infarction in patients with diabetes mellitus. Eur Heart J 9: 259–264.
  • Pomerantz BJ, Robinson TN, Heimbach JK, Calkins CM, Miller SA, Banerjee A, Harken AH (2000) Selective mitochondrial KATP channel opening controls human myocardial precondition-ing: too much of a good thing? Surgery 128: 368–373.
  • Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr (1999) Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 33: 119–124.
  • Wikström BG, Ronquist G, Waldenström A (1996) Glyburide enhancement of lactate production in ischemic heart is modified by preconditioning: an in vivo experimental study in pigs by micro-dialysis technique. J Cardiovasc Pharmacol 27: 622–628.
  • Tosaki A, Engelman DT, Engelman RM, Das DK (1996) The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31: 526–536.
  • Bouchard JF, Lamontagne D (1998) Protection afforded by preconditioning to the diabetic heart against ischaemic injury. Cardiovasc Res 37: 82–90.
  • Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC (2000) Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am J Physiol Heart Circ Physiol 278: H1218–H1224.
  • Cleveland JC Jr, Meldrum DR, Cain BS, Banerjee A, Harken AH (1997) Oral sulfonylurea hypo-glycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revis-ited. Circulation 96: 29–32.
  • Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, Kouno Y, Umemura T, Nakamura S, Sato H (2001) Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 38: 1007–1011.
  • Ovunc K (2000) Effects of glibenclamide, a K(ATP) channel blocker, on warm-up phenomenon intype II diabetic patients with chronic stable angina pectoris. Clin Cardiol 23: 535–539.
  • Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W (1999) Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 20: 403–405.
  • Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, Cacciatore F, Longobardi G, Rengo F (1996) Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 27: 1777–1786.
  • Tani M, Suganuma Y, Hasegawa H, Shinmura K, Hayashi Y, Guo X, Nakamura Y (1997) Changes in ischemic tolerance and effects of ischemic preconditioning in middle-aged rat hearts. Circulation 95: 2559–2566.
  • Fenton RA, Dickson EW, Meyer TE, Dobson JG Jr (2000) Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 32: 1371–1375.
  • Schulman D, Latchman DS, Yellon DM (2001) Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 281: H1630–H1636.
  • Przyklenk K, Li G, Whittaker P (2001) No loss in the in vivo efficacy of ischemic precondition-ing in middle-aged and old rabbits. J Am Coll Cardiol 38: 1741–1747.
  • Tomai F, Crea F, Ghini AS, Proietti I, Gaspardone A, Versaci F, De Paulis R, Chiariello L, Giof-fre PA (2000) Ischemic preconditioning during coronary angioplasty is preserved in elderly patients. Ital Heart J 1: 562–568.
  • Lee TM, Su SF, Chou TF, Lee YT, Tsai CH (2002) Loss of preconditioning by attenuated activa-tion of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105: 334–340.
  • Wu ZK, Pehkonen E, Laurikka J, Kaukinen L, Honkonen EL, Kaukinen S, Laippala P, Tarkka MR (2001) The protective effects of preconditioning decline in aged patients undergoing coro-nary artery bypass grafting. J Thorac Cardiovasc Surg 122: 972–978.
  • Longobardi G, Abete P, Ferrara N, Papa A, Rosiello R, Furgi G, Calabrese C, Cacciatore F, Ren-go F (2000) "Warm-up" phenomenon in adult and elderly patients with coronary artery disease: further evidence of the loss of "ischemic preconditioning" in the aging heart. J Gerontol A Biol Sci Med Sci 55: M124–M129.
  • Abete P, Calabrese C, Ferrara N, Cioppa A, Pisanelli P, Cacciatore F, Longobardi G, Napoli C, Rengo F (2000) Exercise training restores ischemic preconditioning in the aging heart. J Am Coll Cardiol 36: 643–650.
  • Schulz R, Post H, Vahlhaus C, Heusch G (1998) Ischemic preconditioning in pigs: a graded phe-nomenon: its relation to adenosine and bradykinin. Circulation 98: 1022–1029.
  • Matsubara T, Minatoguchi S, Matsuo H, Hayakawa K, Segawa T, Matsuno Y, Watanabe S, Arai M, Uno Y, Kawasaki M, Noda T, Takemura G, Nishigaki K, Fujiwara H (2000) Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coro-nary artery disease. J Am Coll Cardiol 35: 345–351.
  • Iliodromitis EK, Kremastinos DT, Katritsis DG, Papadopoulos CC, Hearse DJ. Multiple cycles of preconditioning cause loss of protection in open-chest rabbits (1997) J Mol Cell Cardiol 29: 915–920.
  • Cohen MV, Yang XM, Downey IM (1994) Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74: 998–1004.
  • Grund F, Gjesdal K, Kirkeboen KA, Ilebekk A (1999) Duration of ischemic preconditioning and importance of the size of area at risk in pigs. J Mol Cell Cardiol 31: 1369–1380.
  • Sack S, Mohri M, Arras M, Schwartz ER, Schaper W (1993) Ischemic preconditioning - time course of renewal in the pig. Cardiovasc Res 27: 551–555.
  • Ovize M, Przyldenk K, Kloner RA (1992) Partial coronary stenosis is sufficient and complete reperfusion is mandatory for preconditioning the canine heart. Circ Res 71: 1165–1173.
  • Koning MM, Simonis LA, de Zeeuw S, Nieukoop S, Post S, Verdouw PD (1994) Ischaemic pre-conditioning by partial occlusion without intermittent reperfusion. Cardiovasc Res 28: 1146–1151.
  • Schulz R, Post H, Sakka S, Wallbridge DR, Heusch G (1995) Intraischemic preconditioning. Increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia with-out intermittent reperfusion. Circ Res 76: 942–950.
  • Post H, Schulz R, Vahlhaus C, Husing J, Hirche H, Gallagher KP, Heusch G (1998) Areas with higher resting BF are more sensetive to ischemia. Impact of Resting and ischemic blood flow on infarct probability in ischemic preconditioning- a new approach to infarctsize-blood flow data by logistic regression. J Mol Cell Cardiol 30: 2719–2728.
  • Huang CH, Kim SJ, Ghaleh B, Kudej RK, Shen YT, Bishop SP, Vatner SF (1999) An adenosine agonist and preconditioning shift the distribution of myocardial blood flow in conscious pigs. Am J Physiol 276: H368–H375.
  • DeFily DV, Chilian WM (1993) Preconditioning protects coronary arteriolar endothelium from ischemia-reperfusion injury. Am J Physiol 265: H700–H706.
  • Kaeffer N, Richard V, Francois A, Lallemand F, Henry JP, Thuillez C (1996) Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am J Physiol 271: H842–H849.
  • Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK (1994) Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemicireperfused rat hearts. J Cardiovasc Pharmacol 23: 365–373.
  • Wikström G, Ronquist G, Waldenström A (1995) Dynamics of myocardial metabolism in pre-conditioned porcine heart studied using continuous microdialysis. Eur Heart J 16; 563–569.
  • Wikström G, Ronquist G, Nilsson S. Maripuu E, Waldenström A (1995) Continuous monitoring of energy metabolites using microdialysis during myocardial ischemia in the pig. Eur Heart J 16; 339–347.
  • Van Wylen DG (1994) Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia.Circulation 89: 2283–2289.
  • Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr (1995) Effects of ischemic and adenosine pre-conditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 269: H1460–H1466.
  • Harrison GJ, Willis RJ, Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 40: 74–87.
  • Pisarenko OI, Tskitishvily OV, Studneva IM, Serebryakova LI, Timoshin AA, Ruuge EK (1997) Metabolic and antioxidant effects of R(±)-N6-(2-phenylisopropy1)-adenosine following regional ischemia and reperfusion in canine myocardium. Biochem Biophys Acta 1361: 295–303.
  • Kitakaze M, Honi M, Takashima S, Sato H, Inoue M, Kamada T (1993) Ischemic precondition-ing increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation 87: 208–215.
  • Kitakaze M, Honi M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada, T (1994) Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237–1246.
  • Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hon i M, Kamada T (1996) Role of activation of protein kinase C in the infarct size-lim-iting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. Circulation 93: 781–791.
  • Przyldenk K, Zhao L, Kloner RA, Elliott GT (1996) Cardioprotection with ischemic precondi-tioning and MLA: role of adenosine-regulating enzymes? Am J Physiol 271: H1004–H1014.
  • Schrader J (1991) Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue. In: Phillis JW Adenosine and Adenine Nucleotides as regulators of cellular function. CRC press, Boca Raton, Fla. pp 55–69.
  • St. Cyr J, Ward H, Kriett J, Alyono D, Einzig S, Bianco R, Anderson R, Foker J (1986) Long term model for evaluation of myocardial metabolic recovery following global ischemia. Adv Exp Med Biol 194: 401–414.
  • Meghji P, Middleton KM, Newby AC (1988) Absolute rates of adenosine formation during ischemia in rat and pigeon hearts. Biochem J 249: 695–703.
  • Chen W, Gueron M (1996) AMP degradation in the perfused rat heart during 2-deoxy-D-glucose perfusion and anoxia. Part II: The determination of the degradation pathways using an adenosine deaminase inhibitor. J Mol Cell Cardiol 28: 2175–2182.
  • Van Wylen DG (1994) Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia.Circulation 89: 2283–2289.
  • Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr (1995) Effects of ischemic and adenosine pre-conditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol 269: H1460–H1466.
  • Harrison GJ, Willis RJ, Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in ischemically preconditioned rat heart. Cardiovasc Res 40: 74–87.
  • Pisarenko OI, Tskitishvily OV, Studneva IM, Serebryakova LI, Timoshin AA, Ruuge EK (1997) Metabolic and antioxidant effects of R(±)-N6-(2-phenylisopropy1)-adenosine following regional ischemia and reperfusion in canine myocardium. Biochem Biophys Acta 1361: 295–303.
  • Mortimer SL, Kodl CT, Reiling CR, Van Wylen DG (2000) Preconditioning-induced attenuation of purine metabolite accumulation during ischemia: memory and multiple cycles. Basic Res Car-diol 95: 119–126.
  • Goto M, Cohen MV, van Wylen DG, Downey JIM (1996) Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of pro-tection. J Mol Cell Cardiol 28: 447–454.
  • Nees S. Herzog V, Becker BF, Bock M, des Rosiers Ch, Gerlach E (1985) The coronary endothelium a highly active metabolic barrier for adenosine. Basic Res Cardiol 80: 515–529.
  • Tsuchida A, Yang XM, Burckhartt B, Mullane KM, Cohen MV, Downey IM (1994) Acadesine extends the window of protection afforded by ischaemic preconditioning. Cardiovasc Res 28: 379–383.
  • Kitakaze M, Hon M, Takashima S, Sato H, Inoue M, Kamada T (1993) Ischemic precondition-ing increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation 87: 208–215.
  • Kitakaze M, Hon M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada, T (1994) Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237–1246.
  • Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hon M, Kamada T (1996) Role of activation of protein kinase C in the infarct size-lim-iting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. Circulation 93: 781–791.
  • Przyklenk K, Zhao L, Kloner RA, Elliott GT (1996) Cardioprotection with ischemic precondi-tioning and MLA: role of adenosine-regulating enzymes? Am J Physiol 271: H1004–H1014.
  • Kitakaze M, Hon M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, et al. (1994) Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity. J Clin Invest 93: 2197–2205.
  • Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hon M, Kamada T (1996) Cardioprotection due to preconditioning correlates with increased ecto-5'-nucleotidase activity. Am J Physiol 270: H238–H244.
  • Komamura K, Kitakaze M, Funaya H, Ueda Y, Node K, Minamino T, Kurihara T, Hon M (1997) Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart. J Cardiovasc Pharmacol 30: 775–783.
  • Schrader J (1991) Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue. In: Phillis JW Adenosine and Adenine Nucleotides as regulators of cellular function. CRC press, Boca Raton, Fla. pp 55–69.
  • Jesmok GJ, Gross GJ, Hardman HF (1978) The effect of adenosine on myocardial metabolism and oxygen consumption in the isolated dog heart preparation. J Mol Cell Cardiol 10: 249–261.
  • Wikstrom G, Kavianipour M, Ronquist G, Waldenström A (2001) Preconditioning activates adenosine utilization in a cost-effective way during myocardial ischemia. Acta Phys Scand 173: 184–195
  • Borgers M, Thone F (1992) Species differences in adenosine metabolic sites in the heart. His-tochem J 24: 445–452.
  • Moriwaki Y, Yamamoto T, Higashino K (1999) Enzymes involved in purine metabolism - a review of histochemical localization and functional implications. Histol Histopathol 14: 1321–1340.
  • Zoref-Shani E, Kessler-Icekson G, Sperling 0 (1988) Pathways of adenine nucleotide catabolism in primary rat cardiomyocyte cultures. J Mol Cell Cardiol 20: 23–33.
  • Crass MF, Lombardini JB (1977) Loss of cardiac muscle taurine after acute left ventricular ischemia. Life Sciences 21: 951–958.
  • Suleiman MS, Moffatt AC, Dihmis WC, Caputo M, Hutter JA, Angelini GD, Bryan AJ (1997) Effects of ischemia and reperfusion on the intracellular concentration of taurine and glutamine in the hearts of patients undergoing coronary artery surgery. Biochim Biophys Acta 1324: 223–231.
  • Kavianipour M (2002) Myocardial energy metabolism in ischemic preconditioning, role of adenosine catabolism. Umed Univesity Medical Dissertations New series No 813. -Lima. ISSN 91-7305-333-3 ISBN 0346–6612 69 pp.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.